Clinical Trials Browser

Phase NA × Interventional × MLN 8237 × Clear all

NCT02530619 2021-05-26

Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia

Phase NA Unknown

26 enrolled 10 charts

MyeloidOther hematologic neoplasm

Leukemia, Megakaryoblastic, Acute, Primary Myelofibrosis